News on Hepatitis continually updated from thousands of sources around the net.
48 min ago | Reuters
A New York hospital on Wednesday alerted more than 4,200 patients who may have received insulin of possible exposure to hepatitis viruses and human immunodeficiency virus due to possible blood contamination, officials and local media said.
Trending on the Topix Network
1 hr ago | Dominion Post
An outbreak of Hepatitis A in the Hutt Valley has spurred public health warnings to make sure vaccinations are up to date.
3 hrs ago | Sacramento Bee Newspaper
If you think your doctor's penmanship is atrocious, it probably is. There's a reason for that: So her signature cannot easily be copied.
8 hrs ago | Voice of America
Rosemary Napeyok in the Nadunget Health Center, located in Karamoja, northeastern Uganda, consults a doctor in Kampala over Skype, March 3, 2014.
12 hrs ago | New Hampshire Public Radio -
Expensive new drugs for hepatitis C may work better than older treatments, but their high cost undermines their value, a panel of experts said Monday during a daylong forum in San Francisco Monday.
16 hrs ago | Medical News Today
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UC San Francisco researchers to specifically weaken immune responses that target transplanted tissue has shown promise in controlled experiments on mice.
20 hrs ago | NEWS.com.au
MORE than 200,000 people in Australia and New Zealand will soon be cured of hepatitis C, thanks to new drugs that have sparked excitement among liver specialists.
The South Nassau Communities Hospital has advised that some patients who received injections from an insulin pen should get tested for hepatitis and HIV.
Slick Aguilar, lead guitarist of Jefferson Starship, has a liver transplant last year and has run up over $1 million in medical bills.
March 11, 2014 - Patrizia Cazzaniga had heard the horror stories about early treatments for hepatitis C - multiple daily pills and weekly shots for up to a year, side effects that could be debilitating, and a cure rate of only about 40 percent.
An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc. A panel of California medical experts voted Monday that Gilead's Sovaldi represents a "low value" ... (more)
Wind Advisory issued March 10 at 3:52PM CDT expiring March 12 at 4:00AM CDT in effect for: Craig, Creek, McIntosh, Mayes, Muskogee, Nowata, Okfuskee, Okmulgee, Osage, Ottawa, Pawnee, Rogers, Tulsa, Wagoner, Washington Fire Weather Warning issued March 11 at 4:57AM CDT expiring March 11 at 10:00PM CDT in effect for: Craig, Creek, Nowata, Okfuskee, ... (more)
An all-oral regimen of daclatasvir plus simeprevir, without interferon or ribavirin, led to sustained response in 85% to 95% of patients with hepatitis C genotype 1b, but this combination did not work well against genotype 1a, researchers reported last week at the 21st Conference on Retroviruses and Opportunistic Infections in Boston.
PrEP researchers Walid Heneine, Gerardo Garcia-Lerma, Peter Anton, and Craig Hendrix during a 2011 CROI panel HIV researchers from across the globe came together in Boston last week from March 3-6 for the annual Conference on Retroviruses and Opportunistic Infections .
A: Many things can be done to help ensure a traveler's health and safety. See your healthcare provider well before your planned departure date.
Variable responses to the Hepatitis B Virus vaccine have recently been reported as strongly dependent on genetic causes.
A new combination of drugs offers a cure for hepatitis C, the virus that often leads to liver disease.